TEMPO.CO, Jakarta - The health equipment producer PT Prodia Diagnostic Line Tbk (PRDL) held an initial public offering (IPO) on the Indonesia Stock Exchange (IDX) on Thursday, July 9, 2026. Prodia is the sixth company to conduct an IPO on the stock exchange this year.
Prodia offered a total of 522.9 million new shares, equivalent to 30 percent of fully paid-up capital after the IPO, at a final price of Rp120 per share. At the opening of trading, PRDL's share price increased by 35 percent to Rp162 per share.
The President Director of Prodia Diagnostic Line, Cristina Sandjaja, stated that the PRDL IPO recorded the highest number of retail orders in history, totaling 1.2 million requests and oversubscribed 709 times. "We see this as the first because Prodia's shares were offered at a very attractive price-to-earnings ratio, indicating the company's good fundamentals, which was appreciated by investors," she told reporters at the Indonesia Stock Exchange.
Cristina admitted that deciding to hold the IPO this year was difficult, given the pressure on the Indonesian capital market. She also noted that the IDX has become stricter in its selection of companies conducting IPOs under the new regulations. Therefore, she believes that investors should feel more relieved because the IPO companies have been well screened.
In terms of performance, the company recorded revenues of Rp74.4 billion in 2025, a 27 percent increase compared to the previous year. Additionally, net profit grew by 70.7 percent to Rp16.9 billion, while EBITDA increased by 66.9 percent to Rp29.2 billion. Based on the audited 2025 financial statements, the final price of PRDL shares was offered at an 8.61 price-to-earnings ratio.
Read: Two Companies Make Stock Market Debut on Indonesia Exchange
Click here to get the latest news updates from Tempo on Google News
